FUJIFILM Diosynth Biotechnologies vs Merck KGaA / MilliporeSigma (CDMO): CDMO Comparison
Side-by-side comparison of FUJIFILM Diosynth Biotechnologies and Merck KGaA / MilliporeSigma (CDMO) on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Merck KGaA / MilliporeSigma (CDMO) has FDA inspections on record (2); FUJIFILM Diosynth Biotechnologies does not yet appear in the FDA inspection database.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- FUJIFILM Diosynth Biotechnologies has materially broader EMA GMP coverage (12 active certificates vs 2) — stronger EU footprint.
- FUJIFILM Diosynth Biotechnologies maintains 6 MHRA / UK GMP certificates; Merck KGaA / MilliporeSigma (CDMO) does not.
- Merck KGaA / MilliporeSigma (CDMO) appears as a manufacturing partner on more matched clinical programs (22 vs 0) — a broader sponsor book.
On a 13-modality CDMO landscape, both FUJIFILM Diosynth Biotechnologies and Merck KGaA / MilliporeSigma (CDMO) qualify as mRNA/LNP manufacturers; FUJIFILM Diosynth Biotechnologies carries the higher composite Signal Score for mRNA/LNP programs in this comparison.
What to evaluate for mRNA/LNP programs
Both FUJIFILM Diosynth Biotechnologies and Merck KGaA / MilliporeSigma (CDMO) qualify as mRNA/LNP CDMOs. When choosing between them for mRNA/LNP programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
IVT mRNA synthesis
Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.
LNP formulation
LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.
Plasmid / starting material
mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.
Cold chain & stability
mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.
Frequently asked: FUJIFILM Diosynth Biotechnologies vs Merck KGaA / MilliporeSigma (CDMO)
Which has the stronger FDA inspection record, FUJIFILM Diosynth Biotechnologies or Merck KGaA / MilliporeSigma (CDMO)?
Both FUJIFILM Diosynth Biotechnologies and Merck KGaA / MilliporeSigma (CDMO) maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. FUJIFILM Diosynth Biotechnologies has 0 FDA inspections on record; Merck KGaA / MilliporeSigma (CDMO) has 2.
How do FUJIFILM Diosynth Biotechnologies and Merck KGaA / MilliporeSigma (CDMO) compare on European GMP coverage?
FUJIFILM Diosynth Biotechnologies holds 12 active EMA GMP certificates and 6 MHRA / UK certificates. Merck KGaA / MilliporeSigma (CDMO) holds 2 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — FUJIFILM Diosynth Biotechnologies or Merck KGaA / MilliporeSigma (CDMO)?
FUJIFILM Diosynth Biotechnologies is matched to 0 ClinicalTrials.gov records as a manufacturing partner; Merck KGaA / MilliporeSigma (CDMO) is matched to 22. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
Which is better for mRNA/LNP manufacturing — FUJIFILM Diosynth Biotechnologies or Merck KGaA / MilliporeSigma (CDMO)?
Both FUJIFILM Diosynth Biotechnologies and Merck KGaA / MilliporeSigma (CDMO) are tagged as mRNA/LNP CDMOs in our directory, so both are credible options for mRNA/LNP programs. The most important differentiator for mRNA/LNP selection is typically ivt mrna synthesis: Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
FUJIFILM Diosynth Biotechnologies carries a Signal Score of 84/100 and Merck KGaA / MilliporeSigma (CDMO) carries 82/100 — essentially tied for FUJIFILM Diosynth Biotechnologies. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →